Log In
Print
BCIQ
Print
Print this Print this
 

Enadenotucirev (formerly ColoAd1)

  Manage Alerts
Collapse Summary General Information
Company PsiOxus Therapeutics Ltd.
DescriptionOncolytic Ad11/Ad3 chimeric group B adenovirus
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today